RE: RNS OUT !30 Mar 2021 08:08
In total 525,000 Ordinary Shares were sold on behalf of Directors and employees and the transactions associated with the Company's directors and persons discharging managerial responsibilities ("PDMRs") were as follows :-
On 26 March 2021, Mr Patrick Elliott, Non Executive Chairman, sold 39,184 Ordinary Shares at a weighted average price of 9.82p per share. Following this sale, Mr Elliott is interested in 9,241,241 Ordinary Shares, equivalent to 2.0% of the voting rights in the Company.
On 26 March 2021, Mr Bruce Grey, Non Executive Director, sold 68,572 Ordinary Shares at a weighted average price of 9.82p per share. Following this sale, Mr Grey is interested in 8,217,004 Ordinary Shares, equivalent to 1.8% of the voting rights in the Company.
On 26 March 2021, Mr Anthony Kongats, Chief Executive Officer, sold 235,105 Ordinary Shares at a weighted average price of 9.82p per share. Following this sale, Mr Kongats is interested in 15,758,561 Ordinary Shares, equivalent to 3.4% of the voting rights in the Company.
On 26 March 2021, Mr Pierre Mars, Vice President of Quality and Applications, sold 29,388 Ordinary Shares at a weighted average price of 9.82p per share.
On 26 March 2021, Mr Mike Taylor, Chief Financial Officer, sold 19,592 Ordinary Shares at a weighted average price of 9.82p per share.
On 26 March 2021, Dr Alex Bilyk, Vice President of Research & Development, sold 58,776 Ordinary Shares at a weighted average price of 9.82p per share.
On 26 March 2021, Mr Song Hee Lau, Sales Manager Asia Pacific, sold 23,266 Ordinary Shares at a weighted average price of 9.82p per share.